Objective:Diabetic nephropathy(DN)is a deleterious microangiopathy of diabetes,constituting a critical determinant of fatality in diabetic patients.This work is purposed to disclose the effects and modulatory mechanis...Objective:Diabetic nephropathy(DN)is a deleterious microangiopathy of diabetes,constituting a critical determinant of fatality in diabetic patients.This work is purposed to disclose the effects and modulatory mechanism of BTG anti-proliferation factor 2(BTG2)during the pathological process of DN.Methods:BTG2 expression in kidney tissues of diabetic mice and high glucose(HG)-exposed human proximal tubular cell line HK-2 was assessed with Western blot and RT-qPCR.The diabetic mice model was constructed by streptozotocin injection and confirmed by the blood glucose level beyond 16.7 mmol/L.Hematoxylin and eosin(H&E)staining and measurement of kidney function hallmarks were conducted to assess kidney injury.Cell counting kit(CCK)-8 method and TUNEL assay appraised cell activity and apoptosis.Oil red O staining assayed lipid accumulation.Relevant commercial kits were used to estimate oxidative stress-related factors.Co-immunoprecipitation(Co-IP)assay testified the binding relationship of BTG2 with protein arginine methyltransferase 1(PRMT1).Results:BTG2 expression was significantly raised in renal tissues of diabetic mice and HK-2 cells exposed to HG.BTG2 deficiency improved viability and extenuated the apoptosis,lipid deposition as well as oxidative stress in HK-2 cells following HG exposure.In addition,PRMT1 was also overexpressed in HK-2 cells exposed to HG.BTG2 interacted with PRMT1 and positively modulated PRMT1 expression.The effects of BTG2 interference on viability,apoptosis,lipid deposition,and oxidative stress in HG-challenged HK-2 cells were partially abrogated by PRMT1 overexpression.Conclusion:Altogether,BTG2 might aggravate HK-2 cell injury in response to HG by binding with PRMT1,providing a novel target for the therapeutic strategy of DN.展开更多
目的用已构建好的BTG2-siRNA重组的慢病毒表达载体包装成具有感染性的慢病毒颗粒,获得稳定BTG2-siRNA表达的A549细胞。方法构建的BTG2-siRNA慢病毒表达载体,经测序后证实与标准序列一致。将BTG2-siRNA慢病毒表达载体与其他两种慢病毒包...目的用已构建好的BTG2-siRNA重组的慢病毒表达载体包装成具有感染性的慢病毒颗粒,获得稳定BTG2-siRNA表达的A549细胞。方法构建的BTG2-siRNA慢病毒表达载体,经测序后证实与标准序列一致。将BTG2-siRNA慢病毒表达载体与其他两种慢病毒包装载体质粒共转染293T细胞,获得BTG2基因siRNA重组慢病毒。感染A549细胞后,用25μg/m L的嘌呤霉素筛选稳定干扰BTG2表达的A549细胞。CCK8法检测感染BTG2干扰慢病毒的A549细胞的增殖能力变化。结果 Western blot检测提示感染BTG2-siRNA慢病毒的A549细胞总蛋白中BTG2表达要明显低于正常的A549细胞。CCK8实验显示,感染BTG2干扰慢病毒的A549细胞的增殖能力增加。结论成功制备了BTG2基因siRNA重组慢病毒颗粒,感染A549细胞后可检测到BTG2蛋白的表达明显降低。为进一步研究BTG2基因在恶性肿瘤中的生物学功能与相关机制的研究奠定了基础。展开更多
MicroRNAs are short regulatory RNAs that negatively modulate gene expression at the post-transcriptional level, and are deeply involved in the pathogenesis of several types of cancers. To investigate whether specific ...MicroRNAs are short regulatory RNAs that negatively modulate gene expression at the post-transcriptional level, and are deeply involved in the pathogenesis of several types of cancers. To investigate whether specific miRNAs and their target genes participate in the molecular pathogenesis of laryngeal carcinoma, oligonucleotide microarrays were used to assess the differential expression profiles of microRNAs and mRNAs in laryngeal carcinoma tissues compared with normal tissues. The oncogeuic miRNA, microRNA-21 （miR-21）, was found to he npregulated in laryngeal carcinoma tissues. Knockdown of miR-21 by specific antisense oligonucleotides inhibited the proliferation potential of HEp-2 cells, whereas overexpression of miR-21 elevated growth activity of the cells, as detected by the colony formation assay. The cell number reduction caused by miR-21 inhibition was due to the loss of control of the G1-S phase transition, instead of a noticeable increase in apoptosis. Subsequently, a new target gene of miR- 21, BTG2, was found to be downregulated in laryngeal carcinoma tissues. BTG2 is known to act as a pan-cell cycle regulator and tumor suppressor. These findings indicate that aberrant expression of miR-21 may contribute to the malignant phenotype of laryngeal carcinoma by maintaining a low level of BTG2. The identification of the oneogenic miR-21 and its target gene, BTG2, in laryngeal carcinoma is potentially valuable for cancer diagnosis and therapy.展开更多
BACKGROUND: The anti-proliferative gene, PC3 (pheochromocytoma cell 3)/BTG2 (B-cell translocation gene 2), is one of the early growth response genes and belongs to the BTG/Tob protein family. This study aimed to asses...BACKGROUND: The anti-proliferative gene, PC3 (pheochromocytoma cell 3)/BTG2 (B-cell translocation gene 2), is one of the early growth response genes and belongs to the BTG/Tob protein family. This study aimed to assess the effects of recombinant human hepatopoietin (HPO) and partial hepatectomy on rapidly induced expression of immediate-early genes and to investigate the expression of PC3/BTG2 mRNA in hepatocellular carcinoma (HCC) at different stages of progression. METHODS: After a rat model of partial hepatectomy was established, we investigated gene expression within I hour after 2/3 partial hepatectomy by representational difference analysis and in a primary cultured hepatocyte system. The expression levels of PC3/BTG2 from liver tissues of the rat model were assessed by RT-PCR and Northern blotting. Meanwhile, the expression of BTG2 mRNA in a tissue microarray of HCC was determined by in situ hybridization. RESULTS: The PC3/BTG2 gene was rapidly induced after 2/3 partial hepatectomy and its expression peaked within 1-2 hours after operation. HPO rapidly induced the expression of the genes c-fos, LRF-1, and PC3 in primary cultured rat hepatocytes, which might be one of the molecular mechanisms by which HPO stimulates hepatocyte proliferation. Positive BTG2 mRNA expression was detected in 71.19% (42/59) of the HCC samples and in 75% (3/4) of the normal liver tissue samples obtained from the region around the HCC tissues. PC3/BTG2 mRNA was located mainly in the cytoplasm of HCC cells and its expression was related to the degree of differentiation. CONCLUSIONS: Recombinant human HPO and partial hepatectomy rapidly induce the expression of the PC3/BTG2 gene. PC3/BTG2 mRNA is highly expressed in HCC cells and its expression is related to the degree of cell differentiation. The abnormal expression of PC3/BTG2 is closely related to the genesis and development of HCC, so PC3/BTG2 may play an important role in these processes. (Hepatobilimy Pancreat Dis Int 2009; 8: 288-293)展开更多
目的研究微小RNA(microRNA,miRNA)miR-25-3p对心肌成纤维细胞纤维化表型的调控及机制。方法血管紧张素Ⅱ(AngⅡ)灌注小鼠构建心肌纤维化模型。用miRNA表达谱芯片检测纤维化的小鼠心肌中表达水平有差异的miRNA。原代分离法获得C57BL/6小...目的研究微小RNA(microRNA,miRNA)miR-25-3p对心肌成纤维细胞纤维化表型的调控及机制。方法血管紧张素Ⅱ(AngⅡ)灌注小鼠构建心肌纤维化模型。用miRNA表达谱芯片检测纤维化的小鼠心肌中表达水平有差异的miRNA。原代分离法获得C57BL/6小鼠心肌成纤维细胞(mCF),建立AngⅡ处理mCF的心肌纤维化细胞模型。mCF转染miR-25-3p mimic后检测纤维化相关基因的表达。双荧光素酶报告基因实验验证miR-25-3p与B细胞易位基因2(BTG2)的3′端非翻译区(3′UTR)的结合作用。放线菌素D实验验证BTG2对超氧化物歧化酶2(SOD2)稳定性的作用。结果miR-25-3p在AngⅡ灌注诱导的小鼠心肌和AngⅡ处理的mCF中表达升高。转染miR-25-3p mimic可使mCF中的Ⅰ型胶原α1(COL1A1)、Ⅲ型胶原α1(COL3A1)和α-平滑肌肌动蛋白(α-SMA)基因表达显著增加。双荧光素酶报告基因实验和功能实验证实BTG2是miR-25-3p的下游靶基因,并参与介导miR-25-3p促进mCF中纤维化相关基因表达的作用。机制研究证实BTG2可通过增加SOD2 m RNA的稳定性而上调其表达。结论miR-25-3p通过抑制BTG2的表达来下调SOD2的水平进而增强纤维化相关基因的表达,发挥促进心肌纤维化的作用。展开更多
基金supported by Key Project of Natural Science Research of Anhui Universities(No.KJ2020A0341).
文摘Objective:Diabetic nephropathy(DN)is a deleterious microangiopathy of diabetes,constituting a critical determinant of fatality in diabetic patients.This work is purposed to disclose the effects and modulatory mechanism of BTG anti-proliferation factor 2(BTG2)during the pathological process of DN.Methods:BTG2 expression in kidney tissues of diabetic mice and high glucose(HG)-exposed human proximal tubular cell line HK-2 was assessed with Western blot and RT-qPCR.The diabetic mice model was constructed by streptozotocin injection and confirmed by the blood glucose level beyond 16.7 mmol/L.Hematoxylin and eosin(H&E)staining and measurement of kidney function hallmarks were conducted to assess kidney injury.Cell counting kit(CCK)-8 method and TUNEL assay appraised cell activity and apoptosis.Oil red O staining assayed lipid accumulation.Relevant commercial kits were used to estimate oxidative stress-related factors.Co-immunoprecipitation(Co-IP)assay testified the binding relationship of BTG2 with protein arginine methyltransferase 1(PRMT1).Results:BTG2 expression was significantly raised in renal tissues of diabetic mice and HK-2 cells exposed to HG.BTG2 deficiency improved viability and extenuated the apoptosis,lipid deposition as well as oxidative stress in HK-2 cells following HG exposure.In addition,PRMT1 was also overexpressed in HK-2 cells exposed to HG.BTG2 interacted with PRMT1 and positively modulated PRMT1 expression.The effects of BTG2 interference on viability,apoptosis,lipid deposition,and oxidative stress in HG-challenged HK-2 cells were partially abrogated by PRMT1 overexpression.Conclusion:Altogether,BTG2 might aggravate HK-2 cell injury in response to HG by binding with PRMT1,providing a novel target for the therapeutic strategy of DN.
文摘目的用已构建好的BTG2-siRNA重组的慢病毒表达载体包装成具有感染性的慢病毒颗粒,获得稳定BTG2-siRNA表达的A549细胞。方法构建的BTG2-siRNA慢病毒表达载体,经测序后证实与标准序列一致。将BTG2-siRNA慢病毒表达载体与其他两种慢病毒包装载体质粒共转染293T细胞,获得BTG2基因siRNA重组慢病毒。感染A549细胞后,用25μg/m L的嘌呤霉素筛选稳定干扰BTG2表达的A549细胞。CCK8法检测感染BTG2干扰慢病毒的A549细胞的增殖能力变化。结果 Western blot检测提示感染BTG2-siRNA慢病毒的A549细胞总蛋白中BTG2表达要明显低于正常的A549细胞。CCK8实验显示,感染BTG2干扰慢病毒的A549细胞的增殖能力增加。结论成功制备了BTG2基因siRNA重组慢病毒颗粒,感染A549细胞后可检测到BTG2蛋白的表达明显降低。为进一步研究BTG2基因在恶性肿瘤中的生物学功能与相关机制的研究奠定了基础。
基金Acknowledgments This work was supported by grants from the National Natural Science Foundation of China （No. 30873017） and the Key Program of the Natural Science Foundation of Tianjing （No. 08JCZDJC23300）. We thank Tianjin First Center Hospital for providing human laryngeal tissue samples. We also thank the College of Public Health of Tianjin Medical University for the technical assistance in fluorescent detection. The ArrayExpress accession numbers of miRNA microarray design and cDNA microarray design are A-MEXP-1506 and A-MEXP-1511. The ArrayExpress accession numbers of miRNA microarray experiment and eDNA microarray experiment are E-MEXP-2039 and E-MEXP-2056.
文摘MicroRNAs are short regulatory RNAs that negatively modulate gene expression at the post-transcriptional level, and are deeply involved in the pathogenesis of several types of cancers. To investigate whether specific miRNAs and their target genes participate in the molecular pathogenesis of laryngeal carcinoma, oligonucleotide microarrays were used to assess the differential expression profiles of microRNAs and mRNAs in laryngeal carcinoma tissues compared with normal tissues. The oncogeuic miRNA, microRNA-21 （miR-21）, was found to he npregulated in laryngeal carcinoma tissues. Knockdown of miR-21 by specific antisense oligonucleotides inhibited the proliferation potential of HEp-2 cells, whereas overexpression of miR-21 elevated growth activity of the cells, as detected by the colony formation assay. The cell number reduction caused by miR-21 inhibition was due to the loss of control of the G1-S phase transition, instead of a noticeable increase in apoptosis. Subsequently, a new target gene of miR- 21, BTG2, was found to be downregulated in laryngeal carcinoma tissues. BTG2 is known to act as a pan-cell cycle regulator and tumor suppressor. These findings indicate that aberrant expression of miR-21 may contribute to the malignant phenotype of laryngeal carcinoma by maintaining a low level of BTG2. The identification of the oneogenic miR-21 and its target gene, BTG2, in laryngeal carcinoma is potentially valuable for cancer diagnosis and therapy.
基金supported by grants from the National Natural Science Foundation of China(Nos.30370341and 30570410)the Academic Foundation for Author of National Excellent Doctoral Dissertation of China(No.200261).
文摘BACKGROUND: The anti-proliferative gene, PC3 (pheochromocytoma cell 3)/BTG2 (B-cell translocation gene 2), is one of the early growth response genes and belongs to the BTG/Tob protein family. This study aimed to assess the effects of recombinant human hepatopoietin (HPO) and partial hepatectomy on rapidly induced expression of immediate-early genes and to investigate the expression of PC3/BTG2 mRNA in hepatocellular carcinoma (HCC) at different stages of progression. METHODS: After a rat model of partial hepatectomy was established, we investigated gene expression within I hour after 2/3 partial hepatectomy by representational difference analysis and in a primary cultured hepatocyte system. The expression levels of PC3/BTG2 from liver tissues of the rat model were assessed by RT-PCR and Northern blotting. Meanwhile, the expression of BTG2 mRNA in a tissue microarray of HCC was determined by in situ hybridization. RESULTS: The PC3/BTG2 gene was rapidly induced after 2/3 partial hepatectomy and its expression peaked within 1-2 hours after operation. HPO rapidly induced the expression of the genes c-fos, LRF-1, and PC3 in primary cultured rat hepatocytes, which might be one of the molecular mechanisms by which HPO stimulates hepatocyte proliferation. Positive BTG2 mRNA expression was detected in 71.19% (42/59) of the HCC samples and in 75% (3/4) of the normal liver tissue samples obtained from the region around the HCC tissues. PC3/BTG2 mRNA was located mainly in the cytoplasm of HCC cells and its expression was related to the degree of differentiation. CONCLUSIONS: Recombinant human HPO and partial hepatectomy rapidly induce the expression of the PC3/BTG2 gene. PC3/BTG2 mRNA is highly expressed in HCC cells and its expression is related to the degree of cell differentiation. The abnormal expression of PC3/BTG2 is closely related to the genesis and development of HCC, so PC3/BTG2 may play an important role in these processes. (Hepatobilimy Pancreat Dis Int 2009; 8: 288-293)
文摘目的研究微小RNA(microRNA,miRNA)miR-25-3p对心肌成纤维细胞纤维化表型的调控及机制。方法血管紧张素Ⅱ(AngⅡ)灌注小鼠构建心肌纤维化模型。用miRNA表达谱芯片检测纤维化的小鼠心肌中表达水平有差异的miRNA。原代分离法获得C57BL/6小鼠心肌成纤维细胞(mCF),建立AngⅡ处理mCF的心肌纤维化细胞模型。mCF转染miR-25-3p mimic后检测纤维化相关基因的表达。双荧光素酶报告基因实验验证miR-25-3p与B细胞易位基因2(BTG2)的3′端非翻译区(3′UTR)的结合作用。放线菌素D实验验证BTG2对超氧化物歧化酶2(SOD2)稳定性的作用。结果miR-25-3p在AngⅡ灌注诱导的小鼠心肌和AngⅡ处理的mCF中表达升高。转染miR-25-3p mimic可使mCF中的Ⅰ型胶原α1(COL1A1)、Ⅲ型胶原α1(COL3A1)和α-平滑肌肌动蛋白(α-SMA)基因表达显著增加。双荧光素酶报告基因实验和功能实验证实BTG2是miR-25-3p的下游靶基因,并参与介导miR-25-3p促进mCF中纤维化相关基因表达的作用。机制研究证实BTG2可通过增加SOD2 m RNA的稳定性而上调其表达。结论miR-25-3p通过抑制BTG2的表达来下调SOD2的水平进而增强纤维化相关基因的表达,发挥促进心肌纤维化的作用。
